Concepedia

Ann Avron

AA

10

Publications

972

Citations

10

H-Index

1985

Active since

Affiliations

Weizmann Institute of Science(Current)

Hebrew University of Jerusalem

Università Campus Bio-Medico

Tel Aviv University

Hadassah Academic College

Ann Avron is an author at Weizmann Institute of Science specializing in medicine, immune regulation, and immunology.

Top concepts

Publications per year

1985–2014

10

Publications

10

β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

Itamar Raz, Dana Elias, Ann Avron et al. · The Lancet · 2001 · 506 citations

, , +9

Heat‐shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double‐blind phase II study

Liora Lazar, R Ofan, Naomi Weintrob et al. · Diabetes/Metabolism Research and Reviews · 2006 · 110 citations

Treatment of new‐onset type 1 diabetes with peptide DiaPep277<b><sup>®</sup></b> is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial

Itamar Raz, Ann Avron, Merana Tamir et al. · Diabetes/Metabolism Research and Reviews · 2006 · 104 citations

IL-2 Induces T Cell Adherence to Extracellular Matrix: Inhibition of Adherence and Migration by IL-2 Peptides Generated by Leukocyte Elastase

Amiram Ariel, Eran J. Yavin, Rami Hershkoviz et al. · The Journal of Immunology · 1998 · 84 citations · Full text

, , +20

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial

Itamar Raz, Anette G. Ziegler, Thomas Linn et al. · Diabetes Care · 2014 · 61 citations · Full text

Rows per page

1–5 of 10